We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+9.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$94.7M
AUM Growth
+$5.36M
(+6%)
Cap. Flow
+$2.1M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
35.56%
Holding
109
New
5
Increased
19
Reduced
37
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$1.57M |
| 2 |
SKYT
SkyWater Technology
SKYT
|
+$1.18M |
| 3 |
8x8 Inc
EGHT
|
+$838K |
| 4 |
Usio Inc
USIO
|
+$566K |
| 5 |
Elutia
ELUT
|
+$255K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$969K |
| 2 |
UPH
UpHealth, Inc.
UPH
|
+$415K |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$335K |
| 4 |
RingCentral
RNG
|
+$221K |
| 5 |
QUMU
Qumu Corp.
QUMU
|
+$148K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.9% |
| 2 | Technology | 21.84% |
| 3 | Communication Services | 7.13% |
| 4 | Industrials | 6.74% |
| 5 | Consumer Staples | 4.38% |
Similar funds
PWP
BF
SFG
HWMG
FTEA
WT
BAM
WLG
Perkins Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Perkins Capital Management held 109 positions worth $94.7M, up 6% from $89.4M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Perkins Capital Management's Q4 2022 filing shows 5 new, 19 increased, 37 reduced and 9 closed positions. Its largest new stake was SkyWater Technology: 140,000 shares worth $995K. The largest sale was CareDx, an estimated $969K.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 57% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q4 2022 buy was SkyWater Technology: 140,000 shares worth $995K.
- Perkins Capital Management added most to Augmedix, Inc. Common Stock in Q4 2022, an estimated $1.57M increase.
- Perkins Capital Management's biggest Q4 2022 reduction was Biolase, Inc., cutting an estimated $124K.
- Perkins Capital Management fully exited CareDx in Q4 2022, selling an estimated $969K.
- Perkins Capital Management's ten largest holdings make up 36% of its $94.7M portfolio in Q4 2022.
- Perkins Capital Management opened 5 new positions and closed 9 in Q4 2022.
- Perkins Capital Management's portfolio value rose 6% quarter-over-quarter to $94.7M.
Based on Perkins Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.